Larkspur Biosciences logo

Larkspur Biosciences

Building the next precision immunotherapies to outsmart cancer.

18 employees · est. 2020 · Watertown, United States

VS
Scancell logo

Scancell

Scancell is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer.

57 employees · est. 1996 · Oxford, United Kingdom

Scancell is the older company (2020 vs 1996); Scancell is the larger of the two.

Side-by-Side Comparison

Larkspur Biosciences Scancell
Founded
2020 1996 older
Headquarters
Watertown, United States Oxford, United Kingdom
Employees
18 57 larger
Industry
Biotechnology, Health Care Biotechnology, Health Care
Funding Stage
Series A Post Ipo Equity
Total Funding
$35.50M $15.65M
Funding Rounds
2 5
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Precision Immunotherapies, Cancer Treatment, Immune System, Molecularly Defined Patient Populations, Colorectal Cancer, LarkX, Target Discovery Platform, Tumor Genetics, Immune Phenotypes, Drug Discovery, Team Collaboration, Culture, Patient-Centric, Innovation Immunology, Cancer, ImmunoBody, Moditope, Cancer Vaccines, AvidiMab, GlyMab, Antibody Platforms, Tumours, Immune System, Cancer Treatment, Prevention, Biopharmaceuticals
Website
larkspur.bio scancell.co.uk
Larkspur Biosciences logo

About Larkspur Biosciences

Larkspur Biosciences Analysis Larkspur Biosciences is a biotechnology startup established in 2020, based in the United States. The company's mission is to develop precision immunotherapies to combat cancer. Their approach is centered around addressing the unique ways tumors manipulate the immune sys...

Scancell logo

About Scancell

Scancell Ltd is a UK-based startup dedicated to using immunology to fight cancer. Established in 1996, the company focuses on developing innovative products that stimulate the immune system to treat or prevent cancer. Operating in the biotechnology and healthcare industries, Scancell aims to address...

We will tell you when either one moves

BounceWatch watches Larkspur Biosciences and Scancell for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Larkspur Biosciences and Scancell — by email.

Frequently Asked Questions

Larkspur Biosciences — Building the next precision immunotherapies to outsmart cancer.. Scancell — Scancell is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Larkspur Biosciences has raised $35.50M while Scancell has raised $15.65M.
Larkspur Biosciences and Scancell operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Larkspur Biosciences with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Larkspur Biosciences on 11 Sep 2024, and Scancell on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes